Psoralea corylifolia extract ameliorates experimental osteoporosis in ovariectomized rats

American Journal of Chinese Medicine

Volumn 35, Issue 4, 2007, Pages 669-680

  Tsai, Meng Hsiun ^a   Huang, Steven G ^b   Hung, Yao Ching ^c,d   Bin, Liu ^d   Liao, Lung Te ^c   Lin, Li Wei ^e  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d KUANG TIEN GENERAL HOSPITAL   (Taiwan)

^e HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Osteoporosis; Ovariectomized; Psoralea corylifolia

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; ESTROGEN; OSTEOCALCIN; PLANT EXTRACT; PSORALEA CORYLIFOLIA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE TURNOVER; CALCIUM BALANCE; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HORMONE SUBSTITUTION; NONHUMAN; OSSIFICATION; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN BLOOD LEVEL; PSORALEA; PSORALEA CORYLIFOLIA; RAT; UPREGULATION; URINARY EXCRETION;

ADMINISTRATION, ORAL; ANIMALS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; CALCIUM; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; FEMALE; OSTEOCALCIN; OSTEOGENESIS; OSTEOPOROSIS; OVARIECTOMY; PHYTOTHERAPY; PSORALEA; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34548182797     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X07005168     Document Type: Article

References (28)

1. An, S.J., T. Li and E. Li. Effect of kidney-tonifying herbs on ovary function and bone mass in postmenopausal women. Chin. J. Osteoporos. 6: 55-59, 2000.
2. Beral, V., E. Banks, G. Reeves and P. Appleby. Use of HRT and the subsequent risk of cancer. J. Epidemiol Biostat. 4: 191-210, 1999.
3. Bonjour, J.P., P. Ammann and R. Rizzoli. Importance of preclinical studies in the development of drugs for treatment of osteoporosis: A review related to the 1998 WHO guidelines. Osteoporus. Int. 9: 379-393, 1999.
4. Christenson, R.H. Biochemical markers of bone metabolism: An overview. Clin. Biochem. 30: 573-593, 1997.
5. Cummings, S.R., D.M. Black, M.C. Nevitt, W.S. Browner, J.A. Cauley, H.K. Genant, S.R. Mascioli, J.C. Scott., D.G. Seeley and P. Steiger. Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA 263: 665-668, 1990.
6. Cummings, S.R., D.M. Black, M.C. Nevitt, W. Browner, J. Cauley, K. Ensrud, H.K. Genant, L. Palermo, J. Scott and T.M. Vogt. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 341: 72-75, 1993.
7. Davison, S. and S.R. Davis. Hormone replacement therapy: Current controversies. Clin. Endocrinol. (Oxf) 58: 249-261, 2003.
8. Delmas, P.D. Biochemical markers of bone turnover. J. Bone Miner. Res. 8(Suppl. 2): S549-S555, 1993.
9. Glazier, M.G. and M.A. Bowman. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern. Med. 161: 1161-1172, 2001.
10. Kalu, D.N. The ovariectornized rat model of postmenopausal bone loss. Bone Miner. 15: 175-191, 1991.
11. Kang, H.J., R. Ansbacher and M.M. Hammond. Use of alternative and complementary medicine in menopause. Int. J. Gynaecol. Obstet. 79: 195-207, 2002.
12. Klemetti, E., P. Vainio, V. Lassila and E. Alhava. Scand J. Dent. Res. 101: 166-170, 1993.
13. Myburgh, K.H., T.D. Noakes, M. Roodt and F.S. Hough. Effect of exercise on the development of osteoporosis in adult rats. J. Appl. Physiol. 66: 14-19, 1989.
14. Nagy, T.R. and A.L. Clair. Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice. Obes. Res. 8: 392-398, 2000.
15. Omi, N. and I. Ezawa. The effect of ovariectomy on bone nietabolism in rats. Bone 17: 163S-168S, 1995.
16. Patlas, N., Y. Zadik., P. Yaffe, Z. Schwartz and A. Ornoy. Oophorectomy-induced osteopenia in rats in relation to age and time postoophorectomy. Cell Tissues Organs 166: 267-274, 2000.
17. Persson, I., E. Weiderpass, L. Bergkvist, R. Bergstrom and C. Schairer. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control 10: 253-260, 1999.
18. Pharmacopoeia of the People's Republic of China. Chemical Industry Publications, Beijing, 2005, Vol. I, pp. 129-130.
19. Price, PA., M.K. Williamson and J.W. Lothringer. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J. Biol. Chem. 256: 12760-12766, 1981.
20. Riggs, B.L. and L.J. Melton, 3rd, Involutional osteoporosis. N. Engl. J. Med. 314: 1676-1686, 1986.
21. Robey, P.G. and A.L. Boskey. The biochemistry of bone. Endocrinol Meta & Clin. North Am. 18: 858-902,1989.
22. Thompson, D.D., H.A. Simmons, C.M. Pirie and H.Z. Ke. FDA Guidelines and animal models for osteoporosis. Bone 17: 125S-133S, 1995.
23. Turner, R.T., B.L. Riggs and T.C. Spelsberg. Skeletal effects of estrogen. Endocr Rev. 15: 275-300, 1994.
24. Uesugi, T, T. Toda, K. Tsuji and H. Ishida. Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectornized rats by soy isoflavones, daidzin, genistin, and glycitin. Biol. Pharm. Bull. 24: 368-372, 2001.
25. Wang, D., F. Li and Z. Jiang. Osteoblastic proliferation stimulating activity of Psoralea corylifoblia extract and two of its flavonoids. Planta Med. 67: 748-749, 2001.
26. Ward, W.E., Y.V. Yuan, A.M. Cheung and L.U. Thompson. Exposure to purified lignan from flaxseed (Linum usitatissimum) alters bone development in female rats. Br J. Nutr 86: 499-505, 2001.
27. Yang, T.T. and M.J. Qin. Isolation and structure identification of a new isoflavone from Psoralea corylifolias. Acta Pharmacol. Sin. 41: 76-79, 2006.
28. Zhonghua Ben Cao. State Administration of Traditional Chinese Medicine of the People's Republic of China. Shanghai Scientific and Technical Publications, Shanghai, 2002, Vol. IV, pp. 603-609.